| Accession Number | 0001205703-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D | Common Stock | โ | Mar 17, 2026 | Exercise/Conversion | 7,166 | $61.18 | $438,415.88 | 241,966 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Mar 17, 2026 | Exercise/Conversion | 11,501 | $64.25 | $738,939.25 | 253,467 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Mar 17, 2026 | Sale | 18,667 | $94.24 | $1,759,178.08 | 234,800 | Direct | โ | View Details | |
President, R&D | Employee Stock Option (right to buy) | Derivative | Mar 17, 2026 | Exercise/Conversion | 7,166 | $0.00 | $0.00 | 9,102 | Direct | โ | View Details | |
President, R&D | Employee Stock Option (right to buy) | Derivative | Mar 17, 2026 | Exercise/Conversion | 11,501 | $0.00 | $0.00 | 32,910 | Direct | โ | View Details |